secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001193125-23-291662
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint closes upsized $230M public offering for wet AMD Phase 3 trials
------------------------------------------------------------------------

- Closed upsized public offering of 13,529,411 shares at $17.00/share, raising ~$230M gross.
- Underwriters fully exercised option for 1,764,705 additional shares.
- Net proceeds to fund EYP-1901 wet AMD Phase 3 pivotal trials and early pipeline.
- Joint book-runners: J.P. Morgan, TD Cowen, Guggenheim; Cantor as additional book-runner.
- Offerings were upsized from $175M initial to $200M priced, then $230M at close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000119312523291662/0001193125-23-291662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000119312523291662/d613658d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-291662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer